Biocardia update on cell therapy product development and 2021 milestones

San carlos, calif., feb. 02, 2021 (globe newswire) -- biocardia®, inc. [nasdaq: bcda] a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today provides an update on its cell therapy product development and 2021 milestones.

BCDA Ratings Summary

BCDA Quant Ranking